Cancer

Marie Borum, MD, MPH, professor of medicine, was mentioned in The Washington Post's coverage of the International Conference on Nutrition in Medicine. Borum presented at the conference on racial disparities in colorectal cancer deaths.

Hoth Therapeutics, Inc. has entered into a sponsored research agreement with GW to explore the potential use of Aprepitant for topical and/or systemic therapy to counter the dermatological related side-effects of Erlotinib therapy in cancer patients.

Kimberly Cabe, FNP-BC, a graduate student in the Integrative Medicine Program, was awarded a grant from the BUCK Cancer Foundation.

Vishal Patel, MD, director of the Cutaneous Oncology Program at GW Cancer Center and assistant professor of dermatology, spoke to Today Online for an article on nail melanoma.

Rong Li, PhD, is conducting research on the regulation of estrogen receptor beta signaling in carcinogenesis.

Lopa Mishra, MD, professor of surgery at SMHS, was inducted into the Association of American Physicians.

A team at the GW Cancer Center found that the deubiquitinating enzyme USP15 is a potential biomarker for treatments of breast and pancreatic cancers.

The GW School of Medicine and Health Sciences will have a presence at the 2019 AAAS Annual Meeting, Feb. 14–17 in Washington, D.C.

Micael Lopez-Acevedo, MD, assistant professor of obstetrics and gynecology, spoke to TIME for an article about AI technology in cervical cancer screenings.

Nita Seibel, MD, clinical professor of pediatrics, spoke to The Washington Post for an article about a patient who's leg was amputated when she was a child and who now plays varsity basketball.